Risk of Hepatitis B Virus Reactivation in Patients Undergoing Allografting

NCT00876148 · Status: COMPLETED · Type: OBSERVATIONAL

Last updated 2009-04-06

No results posted yet for this study

Summary

The purpose of this study is to evaluate the risk of hepatitis B reactivation in patients undergoing allografting.

Conditions

Sponsors & Collaborators

  • Azienda Ospedaliera San Giovanni Battista

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • Italy

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00876148 on ClinicalTrials.gov